155 related articles for article (PubMed ID: 20218099)
21. Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma.
Dalianis T
Presse Med; 2014 Dec; 43(12 Pt 2):e429-34. PubMed ID: 25455638
[TBL] [Abstract][Full Text] [Related]
22. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
Guo T; Eisele DW; Fakhry C
Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
[TBL] [Abstract][Full Text] [Related]
23. Vaccination strategies for the treatment and prevention of cervical cancer.
Schreckenberger C; Kaufmann AM
Curr Opin Oncol; 2004 Sep; 16(5):485-91. PubMed ID: 15314520
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus in head and neck cancers: biology, prognosis, hope of treatment, and vaccines.
Psyrri A; Boutati E; Karageorgopoulou S
Anticancer Drugs; 2011 Aug; 22(7):586-90. PubMed ID: 21403517
[TBL] [Abstract][Full Text] [Related]
25. [Prevention of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues].
Monsonego J
Presse Med; 2007 Apr; 36(4 Pt 2):640-66. PubMed ID: 17350792
[TBL] [Abstract][Full Text] [Related]
26. A Contemporary Review of HPV and Penile Cancer.
Stratton KL; Culkin DJ
Oncology (Williston Park); 2016 Mar; 30(3):245-9. PubMed ID: 26984219
[TBL] [Abstract][Full Text] [Related]
27. Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?
Isaranuwatchai W; Graham DM; Siu LL; Hoch JS
Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):763-5. PubMed ID: 25095728
[TBL] [Abstract][Full Text] [Related]
28. The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment.
Bogani G; Leone Roberti Maggiore U; Signorelli M; Martinelli F; Ditto A; Sabatucci I; Mosca L; Lorusso D; Raspagliesi F
Crit Rev Oncol Hematol; 2018 Feb; 122():92-97. PubMed ID: 29458794
[TBL] [Abstract][Full Text] [Related]
29. HPV Infection of the Head and Neck Region and Its Stem Cells.
Pullos AN; Castilho RM; Squarize CH
J Dent Res; 2015 Nov; 94(11):1532-43. PubMed ID: 26353884
[TBL] [Abstract][Full Text] [Related]
30. The interplay between HPV and host immunity in head and neck squamous cell carcinoma.
Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M
Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554
[TBL] [Abstract][Full Text] [Related]
31. Indications and efficacy of the human papillomavirus vaccine.
Hakim AA; Lin PS; Wilczynski S; Nguyen K; Lynes B; Wakabayashi MT
Curr Treat Options Oncol; 2007 Dec; 8(6):393-401. PubMed ID: 18172770
[TBL] [Abstract][Full Text] [Related]
32. Moving forward with human papillomavirus immunotherapies.
Çuburu N; Schiller JT
Hum Vaccin Immunother; 2016 Nov; 12(11):2875-2880. PubMed ID: 27388123
[TBL] [Abstract][Full Text] [Related]
33. Preventive and therapeutic HPV vaccines.
Monie A; Hung CF; Wu TC
Curr Opin Investig Drugs; 2007 Dec; 8(12):1038-50. PubMed ID: 18058574
[TBL] [Abstract][Full Text] [Related]
34. Unravelling the biology of human papillomavirus (HPV) related tumours to enhance their radiosensitivity.
Vozenin MC; Lord HK; Hartl D; Deutsch E
Cancer Treat Rev; 2010 Dec; 36(8):629-36. PubMed ID: 20417037
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
[TBL] [Abstract][Full Text] [Related]
36. Human Papillomavirus-Related Cancers.
Li Y; Xu C
Adv Exp Med Biol; 2017; 1018():23-34. PubMed ID: 29052130
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus vaccines for cervical cancer.
Murakami M; Gurski KJ; Steller MA
J Immunother; 1999 May; 22(3):212-8. PubMed ID: 10335480
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus vaccines for the treatment of cervical cancer.
Sin JI
Expert Rev Vaccines; 2006 Dec; 5(6):783-92. PubMed ID: 17184217
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus vaccine: a new chance to prevent cervical cancer.
Monk BJ; Mahdavi A
Recent Results Cancer Res; 2007; 174():81-90. PubMed ID: 17302188
[TBL] [Abstract][Full Text] [Related]
40. Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers.
Ling M; Kanayama M; Roden R; Wu TC
J Biomed Sci; 2000; 7(5):341-56. PubMed ID: 10971133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
